D-4-Hydroxyphenylglycine is a non-proteogenic amino acid and a key structural component of vancomycin and related glycopeptide antibiotics. It is produced via the shikimic acid pathway and serves as a pharmaceutical intermediate in antibiotic manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing D-4-Hydroxyphenylglycine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
3-Acetyl-1-(dimethylamino)-4,4a,6,7,11-pentahydroxy-11-methyl-11,11a,12,12a-tetrahydrotetracene-2,5(1H,4aH)-dione
pharmaceutical raw material
Taltobulin
pharmaceutical raw material
Miconazole nitrate
pharmaceutical raw material
Lenacapavir
pharmaceutical raw material
Anisomycin
pharmaceutical raw material
Oxfenicine
pharmaceutical intermediate
4-hydroxyphenylglycine
pharmaceutical intermediate
The international HS code for D-4-Hydroxyphenylglycine (CAS 22818-40-2) is 2922.50.
2922.50
2922 50 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(2R)-2-amino-2-(4-hydroxyphenyl)acetic acid
LJCWONGJFPCTTL-SSDOTTSWSA-N
C1=CC(=CC=C1[C@H](C(=O)O)N)O
Sourcing D-4-Hydroxyphenylglycine?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.